Key result
Epicardial botulinum toxin injection emerges as a targeted strategy to prevent postoperative AF.
Why the study?
Postoperative atrial fibrillation remains very common despite decreases in other postoperative cardiac surgery complications.
Key points are not available for this paper at this time.
Design
Other
Answers are grounded in this paper and cite their sources.
Epicardial botulinum toxin injection remains investigational for postoperative AF prevention; leaves open its clinical role pending randomized trials.
Although the incidence of many postoperative cardiac surgery complications has decreased over the last several decades, postoperative atrial fibrillation (POAF) remains very common. Between 10% and...
No takes yet. Share an insight, caveat, or question.
John J. Squiers (2024) studied this question. Epicardial injection of botulinum toxin is discussed as an ongoing approach to prevent postoperative atrial fibrillation, a complication that remains very common in cardiac surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: